Home LiteratureArticle Details
PMID: 6357642 Published · ppublish English Historical Article Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The Eck fistula in animals and humans.

Current problems in surgery ·Vol. 20 ·No. 11 ·1983-11-00 ·Pages 687-752

Starzl TE, Porter KA, Francavilla A

Abstract

In all species so far studied, including man, portacaval shunt causes the same changes in liver morphology, including hepatocyte atrophy, fatty infiltration, deglycogenation, depletion and disorganization of the rough endoplasmic reticulum (RER) and its lining polyribosomes, and variable but less specific damage to other organelles. Many, perhaps all, biosynthetic processes are quickly depressed, largely secondary to the selective damage to the RER, which is the "factory" of the cell. These structural and metabolic changes in the liver after portal diversion are caused by the diversion around the liver of the hepatotrophic substances in portal venous blood, of which endogenous insulin is the most important. In experimental animals, the injury of Eck's fistula can be prevented by infusing insulin into the tied-off hilar portal vein. The subtle but far-reaching changes in hepatic function after portal diversion have made it possible to use this procedure in palliating three inborn errors of metabolism: glycogen storage disease, familial hypercholesterolemia, and alpha 1-antitrypsin deficiency. In these three diseases, the abnormalities caused by portal diversion have counteracted abnormalities in the patients that were caused by the inborn errors. In these diseases, amelioration of the inborn errors depends on the completeness of the portal diversion. In contrast, total portal diversion to treat complications of portal hypertension is undesirable and always will degrade hepatic function if a significant amount of hepatopetal portal venous blood is taken from the liver. When total portal diversion is achieved (and this is to be expected after all conventional shunts), the incidence of hepatic failure and hepatic encephalopathy is increased. If portal diversion must be done for the control of variceal hemorrhage, a selective procedure such as the Warren procedure is theoretically superior to the completely diverting shunt. In practice, better patient survival has not been achieved after selective shunts than after conventional shunts, but the incidence of hepatic encephalopathy has been less.

MeSH Terms
Animals Child Child, Preschool Dogs Glycogen Storage Disease/physiopathology,surgery History, 19th Century History, 20th Century Humans Hyperlipoproteinemia Type II/physiopathology,surgery Hypertension, Portal/physiopathology,surgery Infant Lipids/blood Liver/pathology,physiology Liver Circulation Liver Transplantation Portacaval Shunt, Surgical/history,methods alpha 1-Antitrypsin Deficiency
Chemicals
Lipids
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Starzl T E
Porter K A
Francavilla A
References (206)
206 references, click to expand
  1. Sex-dependent differences in the effects of portacaval anastomosis on hepatic monooxygenases in rats.
    Biochem Pharmacol. 1982 Feb 15;31(4):499-502 PMID: 6802138
  2. A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation.
    Ann Surg. 1971 Oct;174(4):672-701 PMID: 5098227
  3. Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.
    Lancet. 1976 Apr 17;1(7964):821-5 PMID: 56646
  4. Portal hemodynamics, intestinal absorption, and postshunt encephalopathy.
    Surgery. 1983 Aug;94(2):126-33 PMID: 6879434
  5. The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts.
    Ann Surg. 1974 Oct;180(4):573-9 PMID: 4416359
  6. Fine structural and growth characteristics of cultured rat liver cells. Insulin effects.
    Exp Cell Res. 1972 Mar;71(1):49-58 PMID: 4554574
  7. LIVER DEGLYCOGENATION AFTER PORTACAVAL TRANSPOSITION.
    Surg Forum. 1964;15:120-2 PMID: 14189279
  8. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.
    Br J Surg. 1973 Oct;60(10):797-800 PMID: 4542942
  9. Portacaval shunt with arterialization of the portal vein by means of a low flow arteriovenous fistula.
    Surg Gynecol Obstet. 1978 Jun;146(6):869-76 PMID: 653559
  10. Effect of portasystemic shunt operations on hepatic portal perfusion.
    Am J Surg. 1981 Jan;141(1):169-74 PMID: 7457721
  11. Membranoproliferative glomerulonephritis in childhood cirrhosis associated with alpha1-antitrypsin deficiency.
    Pediatrics. 1976 Feb;57(2):232-8 PMID: 1082572
  12. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts.
    Am J Surg. 1979 Jan;137(1):13-21 PMID: 310249
  13. Angiographic investigations in portal hypertension.
    Surg Gynecol Obstet. 1970 Jan;130(1):37-53 PMID: 4312013
  14. Hepatic adenomata with type 1 glycogen storage disease.
    JAMA. 1976 Sep 27;236(13):1481-4 PMID: 183026
  15. Angiography in portal hypertension: clinical significance in surgery.
    Am J Surg. 1980 Jan;139(1):132-41 PMID: 7350837
  16. Ammonia absorption from the canine colon after portacaval shunt.
    Br J Surg. 1977 Dec;64(12):851-6 PMID: 22373
  17. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.
    Proc Natl Acad Sci U S A. 1975 Mar;72(3):1092-6 PMID: 236556
  18. Low density and high density lipoprotein turnover following portacaval shunt in swine.
    J Lipid Res. 1976 Sep;17(5):441-50 PMID: 184221
  19. Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia.
    Lancet. 1974 Sep 21;2(7882):714-5 PMID: 4142980
  20. Effect of insulin on ultrastructure and glycogenesis in primary cultures of adult rat hepatocytes.
    J Cell Biol. 1977 Sep;74(3):878-900 PMID: 409722
  21. Dacron interposition shunts for portal hypertension. An analysis of morbidity correlates.
    Ann Surg. 1980 Jul;192(1):9-17 PMID: 6447485
  22. Infantile cirrhosis with hereditary alpha 1 -antitrypsin deficiency. Clinical improvement in two siblings.
    Am J Dis Child. 1973 Jun;125(6):845-7 PMID: 4196606
  23. Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy.
    Hepatology. 1983 Jul-Aug;3(4):581-7 PMID: 6862371
  24. Physical-chemical basis of lipid deposition in atherosclerosis.
    Science. 1974 Jul 19;185(4147):222-9 PMID: 4833824
  25. Decreased cholesterol and fatty acid synthesis following portacaval shunt.
    Surg Forum. 1977;28:397-9 PMID: 617481
  26. Portacaval shunt in the rat.
    Surgery. 1961 Oct;50:668-72 PMID: 14463560
  27. The inter-liver competition and portal blood in regeneration of auxiliary liver transplants.
    Surg Forum. 1971;22:341-3 PMID: 4941322
  28. Enhancement of skin homografts by active immunization.
    Surg Forum. 1965;16:243-5 PMID: 5319669
  29. The effect upon the liver of evisceration with or without hormone replacement.
    Surg Gynecol Obstet. 1978 Apr;146(4):524-32 PMID: 205003
  30. Ammonia metabolism in man.
    Ann Surg. 1954 Oct;140(4):539-56 PMID: 13198089
  31. Survival of allografts after hepatic portal venous administration of specific transplantation antigen.
    Ann Surg. 1969 Nov;170(5):824-32 PMID: 4899836
  32. Immunogenic sub-cellular particles obtained from spleens of antigen-injected mice.
    Nature. 1962 Aug 4;195:457-8 PMID: 13894735
  33. An investigation of the relationship between portal venous pressure and inferior vena caval and portal venous oxygen saturations.
    Ann Surg. 1957 Oct;146(4):691-9 PMID: 13470759
  34. [End to side porto-caval shunt in familial type II homozygote hypercholesterolemia (author's transl)].
    Chir Pediatr. 1979;20(3):221-6 PMID: 487516
  35. Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts. A preliminary report.
    Gastroenterology. 1977 Aug;73(2):279-84 PMID: 873129
  36. The effects of portacaval shunt and portal flow occlusion on canine auxiliary liver homotransplants.
    Surgery. 1967 May;61(5):733-8 PMID: 5337422
  37. Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia.
    S Afr Med J. 1976 Feb 21;50(8):239-43 PMID: 176738
  38. The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons.
    Surg Gynecol Obstet. 1975 Mar;140(3):381- 96 PMID: 18689027
  39. Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals.
    Postgrad Med J. 1974 Jun;50(584):365-75 PMID: 4549449
  40. A controlled study of the prophylactic portacaval shunt. A final report.
    Ann Intern Med. 1969 Apr;70(4):675-88 PMID: 4890511
  41. Long-term hypolipidemic effect of portacaval transposition and distal intestinal resection without change in liver function tests.
    J Surg Res. 1982 May;32(5):423-8 PMID: 7087431
  42. Portacaval shunt in the pig 1. Effect on survival, behavior, nutrition, and liver function.
    J Surg Res. 1974 Dec;17(6):387-96 PMID: 4155012
  43. Coma with increased amino acids of brain and cerebrospinal fluid in dogs with Eck's fistula; prevention by portal-systemic collateral circulation.
    AMA Arch Surg. 1957 Sep;75(3):405-12 PMID: 13457614
  44. Treatment of homozygous familial hypercholesterolaemia with portacaval shunt.
    Atherosclerosis. 1982 Feb;41(2-3):349-61 PMID: 7066082
  45. Carcinoma of the head of the pancreas: resection of the portal vein and portacaval shunt.
    Ann Surg. 1958 Jun;147(6):935-44 PMID: 13534264
  46. Hemodynamic variables and prognosis following portacaval shunts.
    Surg Gynecol Obstet. 1974 Mar;138(3):359-69 PMID: 4811321
  47. Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia.
    J Clin Invest. 1954 Jan;33(1):1-9 PMID: 13117957
  48. Portasystemic venous shunts (first of two parts).
    N Engl J Med. 1976 Jul 1;295(1):24-9 PMID: 1083939
  49. Editorial: Promises! Promises! Hemodynamics and portal-systemic shunt.
    N Engl J Med. 1974 Jun 27;290(26):1484-5 PMID: 4275484
  50. Portacaval shunt in four patients with homozygous hypercholesterolaemia.
    Lancet. 1975 Apr 12;1(7911):832-5 PMID: 48058
  51. PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION.
    Surg Gynecol Obstet. 1965 Jul;121:17-31 PMID: 14314095
  52. Late sequelae of mesocaval shunts in children.
    Am J Surg. 1974 Jan;127(1):19-24 PMID: 4543448
  53. The liver as a lymphocyte antigen modifier.
    Surg Forum. 1971;22:280-2 PMID: 4941314
  54. Early history of the portacaval shunt in humans.
    Surg Gynecol Obstet. 1978 Sep;147(3):423-30 PMID: 356307
  55. Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat.
    J Pharmacol Exp Ther. 1976 Feb;196(2):501-9 PMID: 1255494
  56. Insulin as the primary factor governing changes in mitochondrial metabolism leading to liver regeneration and atrophy.
    Am J Surg. 1974 Jun;127(6):669-75 PMID: 4832136
  57. [Electronmicroscopic, morphometric and histologic studies on rat livers after ligature of a portal branch].
    Beitr Pathol. 1972;145(2):119-48 PMID: 5029851
  58. A comparison of portal and systemic venous drainage in porcine renal allografts.
    Br J Surg. 1972 Jul;59(7):541-4 PMID: 4557358
  59. The effect of splanchnic viscera removal upon canine liver regeneration.
    Surg Gynecol Obstet. 1978 Aug;147(2):193-207 PMID: 210529
  60. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.
    J Lab Clin Med. 1969 Jun;73(6):934-9 PMID: 4182334
  61. Hepatic suppression of sensitization to antigen absorbed into the portal system.
    Nature. 1967 Aug 12;215(5102):744-5 PMID: 6059543
  62. The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.
    J Surg Res. 1980 Jan;28(1):1-7 PMID: 6244463
  63. Increased intestinal absorption resulting from portal systemic shunting in the dog and man.
    Surg Forum. 1966;17:367-8 PMID: 5920965
  64. Experimental evaluation of liver atrophy and portacaval shunt.
    Surg Gynecol Obstet. 1967 Dec;125(6):1253-8 PMID: 6065262
  65. Effects of portacaval shunt and transposition on fatty acid and cholesterol biosynthesis in rat liver.
    Am J Physiol. 1980 Aug;239(2):G83-9 PMID: 6157328
  66. Portal venography via the portal and percutaneous splenic routes; anatomic and clinical studies.
    Surgery. 1953 Sep;34(3):557-69 PMID: 13090044
  67. Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization.
    Immunology. 1973 Dec;25(6):941-50 PMID: 4759563
  68. Results of a modified distal spleno-renal shunt for portal hypertension.
    Ann Surg. 1977 Feb;185(2):224-8 PMID: 300005
  69. A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices.
    Surgery. 1979 Mar;85(3):239-45 PMID: 311524
  70. The mechanism of postshunt liver failure.
    Surgery. 1977 Nov;82(5):738-49 PMID: 918862
  71. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Gastroenterology. 1977 Feb;72(2):301-4 PMID: 830579
  72. Effects of portacaval shunt on bile acid metabolism in dogs.
    Surg Forum. 1977;28:402-3 PMID: 364729
  73. Determination of mechanism of enhancement of tumor take by transhepatic passage of antigen.
    Surg Forum. 1972;23(0):116-8 PMID: 4671045
  74. Obliteration of esophageal varices by PTP: a follow-up of 43 patients.
    Ann Surg. 1979 Oct;190(4):549-54 PMID: 384946
  75. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.
    J Clin Invest. 1975 Dec;56(6):1420-30 PMID: 172531
  76. A clarification of some hemodynamic changes in cirrhosis and their surgical significance.
    Ann Surg. 1959 Sep;150:413-27 PMID: 13842955
  77. The effect of experimental diabetes mellitus and insulin replacement on hepatic ultrastructure and protein synthesis.
    J Clin Invest. 1973 Feb;52(2):248-62 PMID: 4683872
  78. Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias.
    Ann Surg. 1974 Oct;180(4):384-92 PMID: 4416064
  79. HOMOTRANSPLANTATION OF THE CANINE LIVER: SURVIVAL AND HISTOLOGY WITH AND WITHOUT AZATHIOPRINE.
    Arch Surg. 1965 Apr;90:527-38 PMID: 14267653
  80. Hepatotrophic substances.
    Prog Liver Dis. 1979;6:135-51 PMID: 396553
  81. The specific influence of nonhepatic splanchnic venous blood flow on the liver.
    Surg Forum. 1965;16:280-2 PMID: 5835158
  82. Sclerotherapy of esophageal varices.
    Arch Surg. 1980 Apr;115(4):476-80 PMID: 6965854
  83. Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia.
    Atherosclerosis. 1977 Nov;28(3):247-56 PMID: 202289
  84. Some effects upon the liver of complete arterialization of its blood supply.
    Surgery. 1952 Aug;32(2):214-18 PMID: 14950607
  85. Cholesterol homeostasis in the rat with a portacaval anastomosis.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4654-7 PMID: 291994
  86. Influence of blood supply on regeneration of liver transplants.
    Surg Forum. 1969;20:369-71 PMID: 4910611
  87. EFFECT OF PARTIAL HEPATECTOMY AND ECK FISTULA ON AUTOTRANSPLANTED LIVER TISSUE. EVIDENCE FOR A HUMORAL MECHANISM IN LIVER REGENERATION.
    Surg Forum. 1963;14:72-4 PMID: 14064594
  88. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
    Gastroenterology. 1984 Apr;86(4):618-26 PMID: 6698363
  89. Portal obstruction in children. II. Results of surgical portosystemic shunts.
    J Pediatr. 1983 Nov;103(5):703-7 PMID: 6605420
  90. Alpha 1-antitrypsin deficiency and infantile liver disease.
    Arch Dis Child. 1976 Aug;51(8):584-8 PMID: 1085610
  91. Transhepatic metabolism after end-to-side portacaval shunt in the young pig.
    Surgery. 1974 Oct;76(4):601-7 PMID: 4416696
  92. Organs transplantation in pig with different portal and caval venous drainage.
    Eur Surg Res. 1971;3(1):62-71 PMID: 4939503
  93. ASSESSMENT OF PORTAL AND HEPATIC HEMODYNAMICS AFTER SIDE-TO-SIDE PORTACAVAL SHUNT IN PATIENTS WITH CIRRHOSIS.
    J Clin Invest. 1964 Jul;43:1464-71 PMID: 14192527
  94. Microsomal drug-metabolizing enzymes activity and induction in the rat liver after portacaval shunt.
    Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196:158- PMID: 5052474
  95. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices.
    N Engl J Med. 1974 Sep 26;291(13):646-9 PMID: 4546968
  96. The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs.
    Surg Gynecol Obstet. 1975 Apr;140(4):549-62 PMID: 18689029
  97. Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts.
    Ann Surg. 1979 Oct;190(4):523-34 PMID: 314787
  98. Hypercholesterolemia, portacaval shunt and coronary disease.
    N Engl J Med. 1979 Jul 12;301(2):108 PMID: 449935
  99. Letter: Portocaval shunt for hypercholesterolaemia.
    S Afr Med J. 1974 Nov 16;48(56):2302 PMID: 4439106
  100. Rate constants for the uptake of cholesterol from various intestinal and serum lipoprotein fractions by the liver of the rat in vivo.
    Biochim Biophys Acta. 1977 Feb 23;486(2):298-307 PMID: 836859
  101. Effect of portal arterialization on hepatic cytochrome P-450 in rats with portacaval shunt.
    Digestion. 1975;12(3):144-51 PMID: 1183748
  102. Portal venous drainage of renal transplants in pigs.
    Transplantation. 1975 Oct;20(4):338-40 PMID: 1099738
  103. Noncirrhotic portal vein thrombosis. Physiology before and after shunts.
    Ann Surg. 1980 Sep;192(3):341-9 PMID: 7416830
  104. An electron microscopic study of lipoprotein production and release by the isolated perfused rat liver.
    Proc Soc Exp Biol Med. 1966 Oct;123(1):4-9 PMID: 5924455
  105. Evolution of liver transplantation.
    Hepatology. 1982 Sep-Oct;2(5):614-36 PMID: 6749635
  106. A comparison of galactose clearance by the liver following portacaval transposition or Eck fistula.
    Surg Forum. 1958;9:515-8 PMID: 13635436
  107. [EXPERIMENTAL PROTACAVAL ANASTOMOSIS IN NORMAL RATS. STUDY OF HEPATIC LESIONS BY MEANS OF ELECTRON MICROSCOPE].
    Pathol Biol (Paris). 1965 Mar;13:288-96 PMID: 14339153
  108. A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation.
    Am J Surg. 1968 Jan;115(1):22-42 PMID: 5299657
  109. Destruction of splenic transplantation antigens by a factor present in liver.
    J Immunol. 1965 Oct;95(4):673-82 PMID: 4953954
  110. Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
    Lancet. 1975 Dec 20;2(7947):1241-2 PMID: 53727
  111. Hepatic circulatory and functional alterations following side-to-side portacaval shunt.
    Surgery. 1966 Jun;59(6):923-31 PMID: 5937966
  112. Effect of portacaval shunt on hepatic cytochrome P-450 in rats.
    Rev Eur Etud Clin Biol. 1972 Oct;17(8):791-3 PMID: 4654286
  113. Peritoneo-venous shunting for ascites.
    Ann Surg. 1974 Oct;180(4):580-91 PMID: 4415019
  114. [Treatment of type II familial hypercholesteremia through portacaval anastomosis].
    Arch Fr Pediatr. 1976 Oct;33(8):745-59 PMID: 185982
  115. Studies on the in vitro effects of insulin on glycogen synthesis and ultrastructure in isolated rat liver hepatocytes.
    Biochem Biophys Res Commun. 1973 Aug 6;53(3):937-43 PMID: 4354454
  116. The Technic of Using Vitallium Tubes in Establishing Portacaval Shunts for Portal Hypertension.
    Ann Surg. 1945 Oct;122(4):476-89 PMID: 17858665
  117. Ten years portal hypertensive surgery at Emory. Results and new perspectives.
    Ann Surg. 1982 May;195(5):530-42 PMID: 7073351
  118. Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices.
    Gastroenterology. 1981 May;80(5 pt 1):1005-11 PMID: 7009309
  119. Hepatic arterialization and portacaval shunt in hepatic cirrhosis. An assessment.
    Arch Surg. 1974 Mar;108(3):315-20 PMID: 4813332
  120. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent.
    Proc Soc Exp Biol Med. 1946 Mar;61:257-9 PMID: 21024163
  121. Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting.
    Arch Surg. 1973 Nov;107(5):659-63 PMID: 4744282
  122. Control of the hyperdynamic circulation in patients with bleeding esophageal varices.
    Ann Surg. 1969 May;169(5):661-71 PMID: 5305164
  123. Effect of increased hepatic blood flow upon liver regeneration.
    AMA Arch Surg. 1954 Aug;69(2):263-72 PMID: 13180085
  124. THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.
    Surgery. 1965 May;57:687-97 PMID: 14295780
  125. Operations for management of esophageal variceal hemorrhage.
    West J Med. 1982 Feb;136(2):107-21 PMID: 7039135
  126. Selectivity of the distal splenorenal shunt.
    Surgery. 1979 Nov;86(5):663-71 PMID: 315102
  127. The Problem of Portal Hypertension in Relation to the Hepatosplenopathies.
    Ann Surg. 1945 Oct;122(4):449-75 PMID: 17858664
  128. Interposition mesocaval shunt for treatment of portal hypertension.
    Ann Surg. 1972 Oct;176(4):435-48 PMID: 4263236
  129. Portacaval transposition in the treatment of glycogen-storage disease.
    Lancet. 1966 Nov 26;2(7474):1146-8 PMID: 4162539
  130. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.
    Surg Gynecol Obstet. 1973 Aug;137(2):179-99 PMID: 4353133
  131. Urea cycle enzyme activity in human hepatic cirrhosis and after experimental portacaval shunt.
    Surg Forum. 1973;24:246-8 PMID: 4805998
  132. Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin, and glucagon levels.
    Arch Surg. 1977 May;112(5):634-6 PMID: 857765
  133. Liver regeneration following portacaval transposition in dogs.
    Ann Surg. 1953 Oct;138(4):600-8 PMID: 13092790
  134. Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins.
    Proc Natl Acad Sci U S A. 1982 Jan;79(1):179-82 PMID: 6948299
  135. ULTRASTRUCTURAL HEPATIC CHANGES FOLLOWING PARTIAL HEPATECTOMY AND PORTACAVAL SHUNT IN THE RAT.
    Lab Invest. 1963 Sep;12:929-42 PMID: 14063413
  136. The effect of portacaval transposition on hepatic cytochrome P-450 in the rat.
    Biomedicine. 1975 Jun 10;23(5):160-2 PMID: 1191728
  137. Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia.
    Lancet. 1976 Dec 25;2(8000):1416 PMID: 63884
  138. Metabolic consequences of portacaval shunting in the rat. Effects on weight, food intake, intestinal absorption and hepatic morphology.
    Z Gesamte Exp Med. 1971;154(2):87-100 PMID: 5102385
  139. Isogenic and allogenic transplatation of isolated langerhans islets into the liver.
    Langenbecks Arch Chir. 1975;Suppl:109-14 PMID: 813071
  140. Control of variceal bleeding. Reassessment of rationale.
    Am J Surg. 1983 Jan;145(1):8-16 PMID: 6600378
  141. The liver as a privileged site for parathyroid alloimplanation in the rat.
    Surgery. 1976 Feb;79(02):182-7 PMID: 1082177
  142. Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery.
    Surgery. 1972 Aug;72(2):306-14 PMID: 4626293
  143. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result?
    Ann Surg. 1974 Feb;179(2):209-18 PMID: 4544047
  144. The response of normal rats to portacaval shunt. A comparative study of end-to-side and side-to-side shunts.
    Arch Surg. 1963 Feb;86:342-8 PMID: 13953856
  145. [Effect of insulin and glucagon on the DNA synthesis hepatocyte cultures].
    Verh Dtsch Ges Inn Med. 1976;82 Pt 1:385-6 PMID: 1029217
  146. Results of left gastric vena caval shunt for esophageal varices: Analysis of one hundred clinical cases.
    Surgery. 1975 Nov;78(5):628-36 PMID: 1188606
  147. A prospective randomized trial of the selective distal splenorenal shunt.
    Surg Gynecol Obstet. 1980 Jan;150(1):45-8 PMID: 6965330
  148. Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizes.
    Proc Natl Acad Sci U S A. 1983 Jan;80(2):564-8 PMID: 6572906
  149. Portacaval shunt in siblings for type I glycogenosis.
    J Pediatr Surg. 1976 Aug;11(4):557-61 PMID: 823318
  150. Prolongation of allogeneic heart graft survival in the rat after implantation on portal vein.
    Transplantation. 1975 Feb;19(2):145-9 PMID: 1091038
  151. Oxygen and CO-2 content in the splanchnic and nonsplanchnic blood of dogs with portacaval transposition.
    Surgery. 1966 Dec;60(6):1229-31 PMID: 5926542
  152. [Selective portohepatic shunt. Pancreatic origin of the portal hepatotrophic factor].
    Ann Chir. 1969 Apr;23(7):393-402 PMID: 5376381
  153. Prophylactic portacaval anastomosis.
    Medicine (Baltimore). 1972 Jan;51(1):27-40 PMID: 4536676
  154. Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt.
    Lancet. 1983 Aug 20;2(8347):424-6 PMID: 6135912
  155. Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion.
    Diabetes. 1970 May;19(5):302-6 PMID: 5443433
  156. ENHANCED ANTIBODY FORMATION IN EXPERIMENTAL ACUTE AND CHRONIC LIVER INJURY PRODUCED BY CARBON TETRACHLORIDE OR ALLYL ALCOHOL.
    Proc Soc Exp Biol Med. 1964 Aug-Sep;116:1060-4 PMID: 14230344
  157. A controlled study of the therapeutic portacaval shunt.
    Gastroenterology. 1974 Nov;67(5):843-57 PMID: 4547724
  158. Canine renal homotransplantation with venous drainage via the portal vein.
    Ann Surg. 1967 Feb;165(2):279-82 PMID: 5334572
  159. Progressive pulmonary hypertension in children with portal hypertension.
    J Pediatr. 1973 Dec;83(6):964-72 PMID: 4757535
  160. Portal pseudoperfusion: an angiographic illusion.
    Ann Surg. 1979 Mar;189(3):257-68 PMID: 556536
  161. Inhibition of second-set renal allograft responses by portal vein drainage.
    Transplant Proc. 1969 Mar;1(1):602-4 PMID: 4944277
  162. Combined hypolipidemia of portacaval transposition and ileal resection in the dog.
    Surg Gynecol Obstet. 1980 Apr;150(4):475-80 PMID: 7361231
  163. Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations.
    Arch Surg. 1966 Jul;93(1):107-18 PMID: 5327725
  164. Immunological unresponsiveness produced in adult guinea pigs by parenteral introduction of minute quantities of hapten or protein antigen.
    Proc Soc Exp Biol Med. 1962 Oct;111:111-5 PMID: 13966867
  165. The effect of partial portacaval transposition on the canine liver.
    Surgery. 1967 May;61(5):723-32 PMID: 4290396
  166. Cholesterol metabolism following portacaval shunt in the pig.
    Atherosclerosis. 1976 Jul-Aug;24(1-2):141-8 PMID: 182182
  167. Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency.
    N Engl J Med. 1980 Jan 31;302(5):272-5 PMID: 6985708
  168. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration.
    Surg Gynecol Obstet. 1975 Dec;141(6):843-58 PMID: 1188560
  169. [Budd-Chiari syndrome associated with Pis or Piso type alpha 1 antitrypsin deficiency. Alpha 1 antitrypsin and the liver: review of the literature].
    Med Chir Dig. 1974;3(6):409-15 PMID: 4549251
  170. Insulin secretion in type I glycogen storage disease.
    Diabetes. 1969 Nov;18(11):755-8 PMID: 5259818
  171. Some effects of porto-caval anastomosis in the male rat.
    Br J Exp Pathol. 1970 Apr;51(2):217-27 PMID: 5420993
  172. Studies of liver lobes autotransplanted outside the abdominal cavity.
    Surg Gynecol Obstet. 1967 Mar;124(3):525-30 PMID: 5335096
  173. Clinical and biochemical findings before and after portacaval shunt in a girl with type Ib glycogen storage disease.
    Pediatr Res. 1981 Jan;15(1):58-61 PMID: 6259580
  174. Hyperglobulinaemia in liver disease.
    Lancet. 1973 Jun 30;1(7818):1494-6 PMID: 4123153
  175. Studies of hepatic function in dogs with Eck fistula or portacaval transposition.
    AMA Arch Surg. 1957 Jun;74(6):964-70 PMID: 13423997
  176. Presidential address: reflections on the early development of portacaval shunts.
    Ann Surg. 1980 May;191(5):519-27 PMID: 6989329
  177. Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis).
    Ann Surg. 1965 Oct;162(4):602-20 PMID: 5833586
  178. Role of insulin as a portal factor in maintaining the viability of liver.
    Ann Surg. 1974 Nov;180(5):716-9 PMID: 4417210
  179. Liver transplantation for type I glycogen storage disease.
    Lancet. 1983 May 14;1(8333):1073-5 PMID: 6133106
  180. Eck fistula encephalopathy: long-term studies in primates.
    Ann Surg. 1971 Jan;173(1):97-103 PMID: 5543554
  181. A randomized, controlled trial of the distal splenorenal shunt.
    Ann Surg. 1978 Sep;188(3):271-82 PMID: 308357
  182. IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER.
    Ann Surg. 1964 Sep;160:411-39 PMID: 14206848
  183. LIVER CELL DAMAGE PRODUCED BY PORTACAVAL SHUNTS.
    Proc Soc Exp Biol Med. 1965 Jan;118:235-7 PMID: 14254556
  184. Portal diversion for the treatment of glycogen storage disease in humans.
    Ann Surg. 1973 Oct;178(4):525-39 PMID: 4517839
  185. Extraction of insulin by liver.
    Annu Rev Med. 1973;24:309-14 PMID: 4575861
  186. Risks in therapeutic portacaval and splenorenal shunts.
    Ann Surg. 1976 Sep;184(3):279-88 PMID: 962396
  187. Portacaval shunt in patients with familial hypercholesterolemia.
    Ann Surg. 1983 Sep;198(3):273-83 PMID: 6615051
  188. [Experimental side to side portocaval anastomosis. Histological and electron microscopic data].
    Lyon Chir. 1972 Nov-Dec;68(6):436-45 PMID: 4659829
  189. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt.
    Ann Surg. 1967 Sep;166(3):437-55 PMID: 6068492
  190. Drug metabolism under pathological and abnormal physiological states in animals and man.
    Xenobiotica. 1977 Jan-Feb;7(1-2):25-92 PMID: 322397
  191. Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site.
    Transplantation. 1977 Oct;24(4):268-73 PMID: 335585
  192. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.
    J Biol Chem. 1974 Aug 25;249(16):5153-62 PMID: 4368448
  193. Successful spleno-renal shunt and splenectomy in two patients with alpha-1-antitrypsin deficiency.
    J Pediatr Surg. 1981 Feb;16(1):12-6 PMID: 6971926
  194. Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting.
    Biochim Biophys Acta. 1982 Aug 18;712(2):250-7 PMID: 7126604
  195. Management of extrahepatic portal hypertension in children.
    Ann Surg. 1974 Oct;180(4):487-93 PMID: 4472192
  196. Lipid and lipoprotein secretion following portacaval shunt in swine.
    Atherosclerosis. 1978 Mar;29(3):355-62 PMID: 208587
  197. Extrahepatic portal hypertension: a retrospective analysis.
    Ann Surg. 1979 May;189(5):566-74 PMID: 312627
  198. Portacaval shunt in hyperlipoproteinaemia.
    Lancet. 1973 Oct 27;2(7835):940-4 PMID: 4126562
  199. Effect of experimental portacaval shunt on hepatic drug metabolizing enzymes.
    Proc Soc Exp Biol Med. 1968 Feb;127(2):444-7 PMID: 5645032
  200. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
    Proc Natl Acad Sci U S A. 1981 Feb;78(2):1194-8 PMID: 6262757
  201. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis.
    Lancet. 1976 Mar 27;1(7961):655-9 PMID: 73637
  202. Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion.
    Ann Surg. 1976 Aug;184(2):155-61 PMID: 821406
  203. RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION.
    J Exp Med. 1920 Apr 30;31(5):609-32 PMID: 19868417
  204. Portacaval shunt for familial heterozygous hypercholesterolemia.
    Surg Gynecol Obstet. 1981 Feb;152(2):187-90 PMID: 7209760
  205. Physiological processes and dynamics in the disposition of small and large doses of biologically active and inactive 131-I-insulins in the rat.
    J Biol Chem. 1967 May 25;242(10):2343-55 PMID: 6026231
  206. Long-term follow-up of distal splenorenal shunts: evaluation by arteriography, shuntography, transhepatic portal venography, and cinefluorography.
    Radiology. 1980 Feb;134(2):341-5 PMID: 7352211
Article Info
Journal
Current problems in surgery
Abbr.
Curr Probl Surg
ISSN
0011-3840
Published
1983-11-00
Pages
687-752
Language
English
Region
United States
NLM ID
0372617
PMCID
PMC3154772
Subset
IM
Grants
NCRR NIH HHS · M01 RR000084 · United States
NIDDK NIH HHS · R01 DK029961-19 · United States
NIADDK NIH HHS · AM 29961 · United States
NCRR NIH HHS · RR 00084 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com